A shadow economy for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are urged to message these accounts privately for source information, while also receiving promotional offers.
Thriving Commerce on Social Networks
Separately, a flourishing market exists on messaging services, where groups with numerous of participants share comparison photos, injection guides and claims of next-day British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Experts Voice Concerns
However, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.
Some professionals said the demand for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the British medical regulations.
Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, risking fines, prosecution or imprisonment.
Platform Reaction and Material Elimination
According to the social media company, the service has taken down problematic content and banned associated hashtags and search suggestions. The organization said it was dedicated to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Investigations also found groups with up to nine thousand members selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays channels with numerous of members, populated with images of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at home.
Within minutes of joining one group, a vendor posted contact information, where the majority of transactions take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about body mass, health issues or previous experience.
Item Details and Pricing
Within these communities, messages display dark colored packages with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When questioned how long a pen should last, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service stated it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are injecting substances they can’t verify. Although the research behind retatrutide is sound, these online products may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using social media. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.
Her staff has previously encountered patients injured by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company experimental product not yet authorized … may expose users to potentially significant medical dangers”.
